Development of alternative technologies to assess muscle functionality

Skeletal muscle is a dynamic tissue that undergoes many regeneration processes during our lifetime. Loss of skeletal muscle is known as muscle atrophy or sarcopenia and is directly related with quality of life and life expectancy. There are very few diagnostic tools to identify muscle atrophy and the ones available are time-consuming and expensive. Therefore, […]

Read More
Development of a lymphatic in-vitro model to study drug uptake

The lymphatic system serves an integral role in fluid homeostasis, lipid metabolism and immune control of the human body. Lipid based nano-carriers employing lymphatic voyage offer multitude of advantages like enhanced bioavailability, selective targeting to localized as well as metastatic conditions, controlled delivery and others. Lipid-based nano-carriers have been tested on various experimental various in-vivo, […]

Read More
Investigating WD repeat protein function in the nucleolar biology and cancer

Ribosome biosynthesis is one of the most multifaceted and energy-demanding processes in biology. It involves over 250 factors that transiently associate with the nascent pre-ribosome in a well-orchestrated manner. Importantly, increased ribosome biogenesis has a critical role in cancer initiation and progression. Owing to the advances in cryo-electron microscopy, this pathway’s detailed mechanism started to […]

Read More
Perioperative Opioid Usage Quality Improvement [CDTS-PDF1] – Year two

Our aim is to use machine-learning to improve treatment of post-surgical pain in children and adults. Most people addicted to opioids were initially exposed through the treatment of pain from trauma and/or surgery. The opioid crisis is reaching the pediatric population, in whom effective post-surgical pain management, with less reliance on prescription of opioids, is […]

Read More
Development of novel oromucosal formulation based on a filmstrip technology for the delivery of psychedelic medications

New evidence about psychedelic remedies has increased the number of patients who potentially can benefit from therapies using these drugs. In clinical trials worldwide, the findings are reported on psychedelic medications for treating illnesses such as addiction, depression, anxiety, and mental health conditions like post-traumatic stress disorder (PTSD). If psychedelic drugs are orally administered, the […]

Read More
Development of a Diclofenac Sodium Quick Kit for FoamaDerm™

The new regulations for pharmacies had catastrophic consequences for the ability of normal pharmacies to compound prescribed preparations for patients using drug powders. Most pharmacies have stopped to offer compounding services at all. This leaves a gap in the ability to provide timely access to needed medicines. The proposed research work will develop an individually […]

Read More
Examining the feasibility and potential impact of a clinical innovative software tool to support pharmacists for minor ailment prescribing

Pharmacists are providing increasingly patient-centered clinical services such as Pharmacists Prescribing for Minor Ailments (PPMA). However, several factors delay pharmacists’ ability to implement PPMA including integration with workflow and time constrains. Technology solutions aim to support PPMA can be important innovative tools to help pharmacists to perform PPMA. The aim of this project is to […]

Read More
Synthesis and characterization of various nanocarriers and ministring DNA product for ocular gene delivery

Gene therapy has the potential to effectively treat a wide range of ocular disorders. However, the introduction of foreign therapeutic genes to cells is incredibly challenging. Compared to viral vectors, non-viral vectors (NVV) are far less immunogenic and less toxic. However, NVV are less efficient than viral vectors at delivering therapeutic genes because they must […]

Read More
A Putative Genetic Disease Model of Schizophrenia

Schizophrenia is a complex neurodevelopmental disorder that affects approximately 1% of the population worldwide. Although research on schizophrenia is ongoing, little is still known about its origin. Schizophrenia is thought to result from a combination of genetic and environmental factors that ultimately lead to decreased brain volume and cortical thickness changes in energy metabolism or […]

Read More
Development of a Pharmacokinetic and Physiologic Model of Different Formulations of an Anti-tumoral Agent

In partnership with Labopharm, a leading company in optimizing the performance of small molecule drugs, a complete pharmacokinetic (PK) study of three new formulations of a commercially available drug will be performed. This study will be conducted in order to choose the most appropriate formulation in terms of bioavailability and absorption rate. Pharmacokinetics parameters of […]

Read More
Development and Pharmacological Evaluation of Novel Oral Amphotericin B Formulations for the Treatment of Experimental Systemic Fungal Infections: Providing New Therapeutic Approach for an Unmet Medical Need in First and Third World Countries

Amphotericin B is the most effective, and frequently the only treatment available for a number of life-threatening diseases, including systemic fungal infections and visceral leishmaniasis. The drawbacks of today’s amphotericin B treatment are toxicity and the need to administer the drug intravenously in hospital settings. The need for intravenous administration is due to poor absorption […]

Read More